Has Sarah Colon received payments from drug or device companies?

Yes. Drug and device makers reported $1,577 in general payments to Sarah Colon across 75 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sarah Colon did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sarah Colon come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sarah Colon

Family · Zanesville, OHNPI 1437746559

Payments from drug & device makers

$1,577in general payments, 2019–2025

Across 75 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$416
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$223
Gilead$143
Corcept Therapeutics$141
Novo Nordisk$95
Lilly USA, LLC$80
plus $478 from 13 others

What the payments were for

Food & beverage$1,577100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	25	$416
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	11	$223
Gilead	3	$143
Corcept Therapeutics	7	$141
Novo Nordisk	1	$95
Lilly USA, LLC	5	$80
Indivior Inc.	4	$77
Braeburn Inc.	1	$67
Edwards Lifesciences	2	$43
Exact Sciences	2	$40
Johnson & Johnson	2	$38
Merck	2	$37
Bayer	2	$37
Viiv Healthcare Company	2	$37
Xeris Pharmaceuticals, Inc.	2	$35
Alkermes, Inc.	1	$20
Otsuka America Pharmaceutical, Inc.	1	$17
Pfizer	1	$16
Medtronic	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Mavyret$103

How this compares

$1,577 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	34	$38,005
Spiriva RespimatTiotropium Bromide	32	$22,122
JanuviaSitagliptin Phosphate	25	$21,960
TrulicityDulaglutide	12	$20,910
RybelsusSemaglutide	11	$19,991
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	11	$7,764
Breo ElliptaFluticasone/Vilanterol	13	$6,327
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	32	$3,676
Lubiprostone	13	$3,263
Albuterol Sulfate HfaAlbuterol Sulfate	132	$2,857
Atorvastatin Calcium	146	$972
Amlodipine Besylate	110	$667
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate	11	$645
Buspirone Hcl	47	$643
Gabapentin	57	$616

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic, Rybelsus	$95	$57,99645 claims
MerckJanuvia	$37	$21,96025 claims
Lilly USA, LLCTrulicity	$80	$20,91012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Zanesville

Carrie AndrewsZanesville$17K
Eileen FauldsLewis Center$991K
Leigh Ann PanschDayton$670K
Natalie BelliniMayfield Heights$582K
Kaitlyn LovettMontgomery$286K
Amy RossDayton$281K
Renee OttSandusky$179K
Megan MillerSpringfield$156K
George KnightCincinnati$130K
Jillian HuntCincinnati$116K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →